Summary:
A study to evaluate an FDA approved once daily oral diabetic medication with new dosages to potentially further improve blood sugar control and increase weight loss in patients with Type 2 Diabetes.
Qualified Participants May Receive:
- Reimbursement for time and travel
- You are provided study-related care and study medicine at no cost (no health insurance required)